随着医学模式的转变,人们已日益认识到,医学的目的不应只是延长生命,更应注重其生活质量。因此,传统评估医药资源投入效益与临床疗效的生物医学指标如生存率、症状缓解率等已显得过于局限。本文从当代医学模式的角度,讨论了生活质量这一指标在评价医药资源投入效益与临床疗效中的意义和策略。 With the transformation of the medical model, people have increasingly realized that the purpose of medicine should not only prolong life, but also pay attention to its quality of life. Therefore, traditional biomedical indicators such as survival rate, symptom remission rate, etc. that have traditionally assessed the effectiveness of medical resource input and clinical efficacy have become too restrictive. From the perspective of contemporary medical model, this article discusses the significance and strategies of the quality of life index in evaluating the effectiveness of medical resources investment and clinical efficacy.